These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 4187543

  • 1. Excretion of urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids by women using steroidal contraceptives.
    Bulbrook RD, Hayward JL.
    Lancet; 1969 Nov 15; 2(7629):1033-5. PubMed ID: 4187543
    [No Abstract] [Full Text] [Related]

  • 2. The urinary excretion of 11-deoxy-17-oxosteroids and 17-hydroxycorticosteroids by normal Japanese and British women.
    Bulbrook RD, Thomas BS, Utsunomiya J, Hamaguchi E.
    J Endocrinol; 1967 Aug 15; 38(4):401-6. PubMed ID: 4226508
    [No Abstract] [Full Text] [Related]

  • 3. Benign and malignant breast disease in South Wales: a study of urinary steroids.
    Cameron EH, Griffiths K, Gleave E, Stewart HJ, Forrest AP, Campbell H.
    Br Med J; 1970 Dec 26; 4(5738):768-71. PubMed ID: 4250592
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the urinary excretion of glucocorticoids and 11-deoxy-17-ketosteroids in a group of obese women.
    Hendrikx A, Meulepas E, Heyns W, De Moor P.
    Ann Endocrinol (Paris); 1974 Dec 26; 35(4):508-20. PubMed ID: 4283406
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of urinary 17-hydroxycorticosteroid and 11-deoxy-17-oxosteroid excretion in obesity, in thyroid dysfunction and in early breast cancer.
    Sneddon A, Steel JM, Strong JA.
    J Endocrinol; 1969 Feb 26; 43(2):48-9. PubMed ID: 4237784
    [No Abstract] [Full Text] [Related]

  • 6. Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey.
    Bulbrook RD, Hayward JL.
    Lancet; 1967 Mar 11; 1(7489):519-22. PubMed ID: 4163897
    [No Abstract] [Full Text] [Related]

  • 7. The urinary dehydroepiandrosterone, androsterone and etiocholanolone excretion of healthy women and women with benign and malignant breast disease.
    Ivanović S, Agbaba D, Zivanov-Stakić D, Konstantinović I.
    J Clin Pharm Ther; 1990 Jun 11; 15(3):213-9. PubMed ID: 2142165
    [Abstract] [Full Text] [Related]

  • 8. The routine measurement of urinary 17-oxosteroids and 17-oxogenic steroids using gas-liquid chromatography.
    Crook D.
    Clin Chim Acta; 1972 Aug 11; 40(1):43-51. PubMed ID: 4262517
    [No Abstract] [Full Text] [Related]

  • 9. Urinary and plasma androgens and their relation to familial risk of breast cancer.
    Wang DY, Bulbrook RD, Hayward JL.
    Eur J Cancer (1965); 1975 Dec 11; 11(12):873-7. PubMed ID: 130241
    [No Abstract] [Full Text] [Related]

  • 10. Excretion of individual 17-oxosteroids and corticosteroids in the urine during childhood and adolescence.
    Savage DC, Forsyth CC, McCafferty E, Cameron J.
    Arch Dis Child; 1971 Dec 11; 46(250):880-1. PubMed ID: 4256899
    [No Abstract] [Full Text] [Related]

  • 11. Normal values for the urinary excretion of some 17-oxosteroids and pregnanediols in healthy male adolescents.
    Slob A, Winkel P.
    Clin Chim Acta; 1973 Mar 30; 44(3):307-18. PubMed ID: 4266537
    [No Abstract] [Full Text] [Related]

  • 12. Discriminant function based on steroid abnormalities in patients with lung cancer.
    Rao LG.
    Lancet; 1970 Aug 29; 2(7670):441-5. PubMed ID: 4195119
    [No Abstract] [Full Text] [Related]

  • 13. Some aspects of the circadian rhythm of the urinary excretion of etiocholanolone, androsterone and dehydroepiandrosterone.
    van Voorst tot Voorst EJ.
    J Clin Chem Clin Biochem; 1982 Jan 29; 20(1):25-8. PubMed ID: 6461715
    [Abstract] [Full Text] [Related]

  • 14. Probability of a woman with advanced breast cancer responding to adrenalectomy or hypophysectomy.
    Sarfaty G, Tallis M.
    Lancet; 1970 Oct 03; 2(7675):685-7. PubMed ID: 4195930
    [No Abstract] [Full Text] [Related]

  • 15. The relationship of urinary androgen metabolites to breast diseases including carcinoma.
    Wetchler BB, McCarrick J, Allerhand J, Dreiling DA.
    Mt Sinai J Med; 1974 Oct 03; 41(5):682-6. PubMed ID: 4278335
    [No Abstract] [Full Text] [Related]

  • 16. Urinary excretion of 11-deoxy-17-ketosteroids by patients with breast cancer with or without ovulatory cycles.
    Grattarola R.
    J Endocrinol; 1967 May 03; 38(1):77-8. PubMed ID: 4225834
    [No Abstract] [Full Text] [Related]

  • 17. Effect of resection of lung tumours on the steroid abnormalities in patients with lung cancer.
    Rao LG.
    Br Med J; 1971 Dec 04; 4(5787):588-90. PubMed ID: 5130212
    [Abstract] [Full Text] [Related]

  • 18. Effect of age, obesity, starvation, and changes in adrenocortical and ovarian activity on the urinary excretion of dehydroepiandrosterone relative to androsterone plus etiocholanolone: relevance to the measurement of breast cancer discriminants in women.
    Metcalf MG.
    Clin Biochem; 1974 Jun 04; 7(2):119-30. PubMed ID: 4276446
    [No Abstract] [Full Text] [Related]

  • 19. Chromatographic separation of 17-ketosteroids and 17-hydroxycorticosteroids on sephadex LH-20.
    Seki T, Sugase T.
    J Chromatogr; 1969 Jul 22; 42(4):503-8. PubMed ID: 4240909
    [No Abstract] [Full Text] [Related]

  • 20. The pattern of urinary excretion of individual 17-ketosteroids in rhesus monkeys.
    Pal SB.
    Acta Endocrinol (Copenh); 1971 Jul 22; 67(4):711-20. PubMed ID: 4254196
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.